Clinical studies investigating the use of leuprorelin in Asian women with endometriosis: a review

Yutaka Osuga; Pao-Ling Torng; Pao‐Ling Torng; Cherng-Jye Jeng; Cherng‐Jye Jeng

doi:10.1080/01443615.2018.1460584

Clinical studies investigating the use of leuprorelin in Asian women with endometriosis: a review

Yutaka Osuga, Pao-Ling Torng, Pao‐Ling Torng, Cherng-Jye Jeng, Cherng‐Jye Jeng

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology · 2019 · vol. 39(3) , pp. 291–296 · doi:10.1080/01443615.2018.1460584 · PMID:30653368 · W2911082970

review OA: closed CC0

View on OpenAlex View on PubMed View at publisher

⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This review of four Asian studies found that leuprorelin significantly improved endometriosis pain and quality of life but decreased hormone levels and bone density, with add-back therapy mitigating hormone reduction.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

We aimed to examine how leuprorelin has been studied for the treatment of women with endometriosis in Asia. We conducted a literature search of PubMed, the Cochrane Library and ClinicalTrials.gov. This review includes randomised trials of women with endometriosis treated with leuprorelin in Asia. Phase I-IV clinical trials published between January 1 2000 and December 31 2016 and written in English were included. Four studies were identified, showing that leuprorelin significantly improves pain and quality of life. The oestrone and oestradiol levels are decreased by leuprorelin but can be increased using an 'add-back' therapy with conjugated equine oestrogen and methoxyprogesterone. Menopause is more common in women treated with leuprorelin. The bone mineral density is reduced in women treated with leuprorelin. There are limited studies investigating the use of leuprorelin for the treatment of endometriosis in Asian populations. However, the research that has been conducted supports the use of leuprorelin in an Asian population.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Leuprolide Asian People Endometriosis Female Gonadotropins Gonadotropins Humans Leuprolide Pain Pain

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (27)

SciLite annotations

chemicals 12

goserelin goserelin goserelin goserelin estrone estradiol goserelin estrogen medroxyprogesterone goserelin mineral goserelin

organisms 2

noordeloos 2009062 noordeloos 2009062

Source provenance

europepmc: last seen: 2026-06-16T06:07:01.518242+00:00
openalex: last seen: 2026-06-10T17:14:06.276822+00:00
pubmed: last seen: 2026-05-13T22:23:01.605684+00:00
scilite: last seen: 2026-05-18T04:26:01.642840+00:00

License: CC0 · commercial use OK

[1] A comparison of progestogens or oral contraceptives and gonadotropin-releasing hormone agonists for the treatment of endometriosis: a systematic review via openalex

[2] Advances in the management of endometriosis: an update for clinicians via openalex

[3] A higher prevalence of endometriosis among Asian women does not contribute to poorer IVF outcomes via openalex

[4] A Prospective Randomized Study Comparing Endocrinological and Clinical Effects of Two Types of GnRH Agonists in Cases of Uterine Leiomyomas or Endometriosis via openalex

[5] Buserelin acetate versus expectant management in the treatment of infertility associated with minimal or mild endometriosis: A randomized clinical trial via openalex

[6] Dienogest increases the progesterone receptor isoform B/A ratio in patients with ovarian endometriosis via openalex

[7] Effect of dienogest on pain and ovarian endometrioma occurrence after laparoscopic resection of uterosacral ligaments with deep infiltrating endometriosis via openalex

[8] Efficacy of Every-Other-Day Administration of Conjugated Equine Estrogen and Medroxyprogesterone Acetate on Gonadotropin-Releasing Hormone Agonists Treatment in Women with Endometriosis via openalex

[9] <i>Endometriosis and Infertility</i> via openalex

[10] Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries via openalex

[11] Introduction via openalex

[12] Long-term follow-up on the treatment of endometriosis with the GnRH-agonist buserelinacetate Long-term follow-up data (up to 98 months) of 42 patients with endometriosis who were treated with GnRH-agonist buserelinacetate (Suprecur®), were evaluated in respect of recurrence of pain symptoms and pregnancy outcome via openalex

[13] Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain via openalex

[14] Minimising menopausal side effects whilst treating endometriosis and fibroids via openalex

[15] Molecular aspects of development and regulation of endometriosis via openalex

[16] Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills via openalex

[17] Rates of Endometriosis Recurrence and Pregnancy 1 Year after Treatment with Intranasal Buserelin Acetate (Suprecur®) (A Prospective Study) via openalex

[18] [Study on leuprorelin acetate in treatment of uterine adenomyosis with infertility]. via openalex

[19] Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain via openalex

[20] W2277353857 via openalex

[21] W1981060751 via openalex

[22] W2615713587 via openalex

[23] W1512318310 via openalex

[24] W1962141530 via openalex

[25] W2151934245 via openalex

[26] W2006390573 via openalex

[27] W2163315477 via openalex